dihydroergotamine has been researched along with caffeine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Angersbach, P; Babej, E; Bollmann, H; Glaser, A; Kolbe, M; Pieschl, D; Schulze, H; von Seck, P | 1 |
| Heyck, H | 1 |
| Fozard, JR | 1 |
| Fanchamps, A | 1 |
| Hill, RC; van Graffenried, B | 1 |
| Bousser, MG; Massiou, H | 1 |
| Cavanaugh, ST; Hoeldtke, RD; Hughes, JD | 1 |
| Cavanaugh, ST; Hoeldtke, RD; Hughes, JD; Polansky, M | 1 |
| Degen, J; Maier-Lenz, H | 1 |
| Bramich, NJ; Cousins, HM | 1 |
| DALSGAARD-NIELSEN, T | 1 |
| Lisotto, C; Maggioni, F; Mainardi, F; Zanchin, G | 1 |
| Cecener, G; Egeli, U; Tunca, B; Yilmazlar, T; Zorluoglu, A | 1 |
| Callison, CR; Kumar, AB; Miller, M | 1 |
| Becker, WJ | 1 |
4 review(s) available for dihydroergotamine and caffeine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The animal pharmacology of drugs used in the treatment of migraine.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Muscle, Smooth; Pizotyline; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission; Tryptamines; Vagus Nerve; Vasoconstrictor Agents; Vasodilator Agents | 1975 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin | 1975 |
Acute Migraine Treatment in Adults.
Topics: Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Dihydroergotamine; Drug Administration Schedule; Female; Humans; Male; Migraine Disorders; Pain Management; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2015 |
3 trial(s) available for dihydroergotamine and caffeine
| Article | Year |
|---|---|
[Combined study of Silentan. Test of a headache remedy in general and clinical practice].
Topics: Adult; Aspirin; Caffeine; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Headache; Humans; Male; Middle Aged | 1979 |
Headache as a model for testing mild analgesics.
Topics: Adult; Aminopyrine; Analgesics; Antipyrine; Aspirin; Barbiturates; Caffeine; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Headache; Humans; Male; Placebos; Quinazolines | 1978 |
Treatment of orthostatic hypotension with dihydroergotamine and caffeine.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Caffeine; Dihydroergotamine; Drug Therapy, Combination; Eating; Female; Humans; Hypotension, Orthostatic; Injections, Subcutaneous; Male; Middle Aged | 1986 |
13 other study(ies) available for dihydroergotamine and caffeine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
[Drug therapy of migraine and cluster headache].
Topics: Analgesics; Barbiturates; Caffeine; Dihydroergotamine; Drug Synergism; Ergot Alkaloids; Headache; Histamine H1 Antagonists; Humans; Methysergide; Migraine Disorders; Vascular Headaches | 1975 |
[Antimigrainous agents. General considerations and treatment of the crisis].
Topics: Acupuncture Therapy; Amitriptyline; Analgesics; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antiemetics; Caffeine; Dihydroergotamine; Ergotamine; Ergotamines; Humans; Migraine Disorders | 1986 |
Management of orthostatic hypotension.
Topics: Blood Pressure; Caffeine; Dihydroergotamine; Humans; Hypotension, Orthostatic | 1987 |
Treatment of orthostatic hypotension: interaction of pressor drugs and tilt table conditioning.
Topics: Caffeine; Dihydroergotamine; Drug Therapy, Combination; Equipment and Supplies; Humans; Hypotension, Orthostatic; Male; Middle Aged; Octreotide | 1988 |
[Comparative pharmacokinetics and relative bioavailability of the active principles diazepam, acetylsalicylic acid, caffeine, and dihydroergotamine tartrate in a combination product].
Topics: Adult; Aspirin; Biological Availability; Caffeine; Diazepam; Dihydroergotamine; Drug Combinations; Humans; Kinetics; Male | 1982 |
Effects of sympathetic nerve stimulation on membrane potential, [Ca2+]i and force in the arrested sinus venosus of the toad, Bufo marinus.
Topics: Animals; Bufo marinus; Caffeine; Calcium; Calcium Channel Blockers; Dihydroergotamine; Electric Stimulation; Heart Rate; Membrane Potentials; Neurons; Ryanodine; Sinoatrial Node; Sympathetic Nervous System; Thapsigargin | 1997 |
[Ergotamine-caffeine and dihydroergotamine-caffeine in migraine therapy].
Topics: Caffeine; Dihydroergotamine; Drug Combinations; Ergot Alkaloids; Ergotamine; Humans; Migraine Disorders; Oxytocics | 1952 |
Episodic hypnic headache?
Topics: Aged; Analgesics, Non-Narcotic; Caffeine; Central Nervous System Stimulants; Dihydroergotamine; Female; Headache Disorders; Humans; Lithium; Male; Sleep Wake Disorders | 2004 |
The mutation spectrum of the APC gene in Turkish patients with familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Aspirin; Biomarkers, Tumor; Caffeine; Diazepam; Dihydroergotamine; Drug Combinations; Gene Deletion; Genes, APC; Heteroduplex Analysis; Humans; Pedigree; Sequence Analysis, DNA; Turkey | 2007 |
Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
Topics: Adult; Caffeine; Cerebral Angiography; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Angiography; Migraine Disorders; Nicardipine; Phosphodiesterase Inhibitors; Stents; Stroke; Vasoconstrictor Agents; Vasodilator Agents; Vasospasm, Intracranial | 2012 |